Group One Trading
TEVA icon

Group One Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Group One Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.5M Sell
548,600
-340,400
-38% -$11M 0.03% 581
2025
Q4 		$27.7M Sell
889,000
-398,600
-31% -$9.82M 0.05% 376
2025
Q3 		$26M Sell
1,287,600
-20,700
-2% -$364K 0.05% 390
2025
Q2 		$21.9M Buy
1,308,300
+2,600
+0.2% +$42K 0.05% 385
2025
Q1 		$20.1M Sell
1,305,700
-183,000
-12% -$3.27M 0.06% 317
2024
Q4 		$32.8M Buy
1,488,700
+908,200
+156% +$16.5M 0.08% 225
2024
Q3 		$10.5M Sell
580,500
-1,387,100
-70% -$24.3M 0.03% 598
2024
Q2 		$32M Buy
1,967,600
+1,524,200
+344% +$23.5M 0.12% 120
2024
Q1 		$6.26M Sell
443,400
-334,700
-43% -$4.22M 0.02% 691
2023
Q4 		$8.12M Buy
778,100
+21,800
+3% +$204K 0.02% 818
2023
Q3 		$7.71M Sell
756,300
-197,600
-21% -$1.84M 0.03% 660
2023
Q2 		$7.18M Sell
953,900
-362,800
-28% -$2.94M 0.02% 712
2023
Q1 		$11.7M Sell
1,316,700
-3,159,700
-71% -$31.2M 0.04% 402
2022
Q4 		$40.8M Sell
4,476,400
-447,900
-9% -$3.91M 0.1% 191
2022
Q3 		$39.7M Sell
4,924,300
-1,806,900
-27% -$16M 0.08% 172
2022
Q2 		$50.6M Buy
6,731,200
+1,959,300
+41% +$17.1M 0.08% 195
2022
Q1 		$44.8M Buy
4,771,900
+170,000
+4% +$1.42M 0.04% 287
2021
Q4 		$36.9M Buy
4,601,900
+3,016,800
+190% +$27.2M 0.03% 399
2021
Q3 		$15.4M Sell
1,585,100
-459,700
-22% -$4.3M 0.02% 765
2021
Q2 		$20.2M Buy
2,044,800
+376,700
+23% +$3.99M 0.02% 623
2021
Q1 		$19.3M Sell
1,668,100
-393,400
-19% -$4.51M 0.03% 555
2020
Q4 		$19.9M Buy
2,061,500
+1,104,600
+115% +$10.6M 0.03% 448
2020
Q3 		$8.62M Sell
956,900
-264,100
-22% -$2.79M 0.03% 603
2020
Q2 		$15.1M Sell
1,221,000
-736,300
-38% -$8.33M 0.07% 309
2020
Q1 		$17.6M Buy
1,957,300
+178,100
+10% +$1.82M 0.14% 128
2019
Q4 		$17.4M Buy
1,779,200
+195,800
+12% +$1.75M 0.12% 180
2019
Q3 		$10.9M Sell
1,583,400
-324,300
-17% -$2.48M 0.09% 252
2019
Q2 		$17.6M Buy
1,907,700
+1,365,000
+252% +$16.5M 0.16% 112
2019
Q1 		$8.51M Sell
542,700
-1,015,700
-65% -$17.9M 0.09% 231
2018
Q4 		$24M Buy
1,558,400
+249,100
+19% +$5.11M 0.21% 84
2018
Q3 		$28.2M Sell
1,309,300
-232,500
-15% -$5.4M 0.22% 70
2018
Q2 		$37.5M Buy
1,541,800
+420,500
+38% +$8.58M 0.32% 39
2018
Q1 		$19.2M Sell
1,121,300
-1,680,700
-60% -$32.8M 0.19% 92
2017
Q4 		$53.1M Buy
2,802,000
+1,296,300
+86% +$19.5M 0.37% 29
2017
Q3 		$26.5M Buy
1,505,700
+620,200
+70% +$14M 0.24% 69
2017
Q2 		$29.4M Buy
885,500
+265,900
+43% +$8.23M 0.31% 46
2017
Q1 		$19.9M Sell
619,600
-785,800
-56% -$26.8M 0.23% 74
2016
Q4 		$50.9M Buy
1,405,400
+1,173,500
+506% +$46.9M 0.49% 25
2016
Q3 		$10.7M Sell
231,900
-30,100
-11% -$1.57M 0.12% 171
2016
Q2 		$13.2M Sell
262,000
-4,900
-2% -$261K 0.16% 119
2016
Q1 		$14.3M Sell
266,900
-97,600
-27% -$5.73M 0.2% 84
2015
Q4 		$23.9M Sell
364,500
-48,100
-12% -$2.97M 0.28% 47
2015
Q3 		$23.3M Buy
412,600
+245,000
+146% +$15.9M 0.32% 30
2015
Q2 		$9.9M Buy
167,600
+86,100
+106% +$5.31M 0.14% 148
2015
Q1 		$5.08M Buy
+81,500
New +$4.74M 0.08% 257

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's TEVA Position: Q1 2026 in Review

Group One Trading sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 320,801 shares — an estimated $10.3M sold.

Group One Trading first reported a position in TEVA in Q1 2015 and held it in 39 quarters. The position peaked at $48.6M in Q4 2021. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Group One Trading reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 320,801 Teva Pharmaceuticals shares in Q1 2026, an estimated $10.3M.
  • Group One Trading first reported a position in Teva Pharmaceuticals in Q1 2015 and held it in 39 quarters.
  • Group One Trading's Teva Pharmaceuticals position peaked at $48.6M in Q4 2021.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.